Evidence map›Paper›PMID 24899758›Full record

ArticleSleep2014

Retrospective population cohort study on hip fracture risk associated with zolpidem medication.

Fang-Yu Lin, Pei-Chun Chen, Chun Hui Liao, Yow-Wen Hsieh, Fung-Chang Sung

Open access · bronzeAbstract read
In one paragraph

Article in Sleep, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Zolpidem use and risk of fractures: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Early-onset dementia and risk of hip fracture and major osteoporotic fractures.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  6. Observational
  7. Article
  8. Article
  9. Responsiveness of Veterans Affairs Health Care System to Zolpidem Safety Warnings.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Fang-Yu LinDepartment of Public Health, China Medical University, Taichung, Taiwan ; Department of Epidemiology, University of Texas School of Public Health, Houston, TX.
Pei-Chun ChenInstitute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
Chun Hui LiaoDepartment of Psychiatry, China Medical University Hospital, Taichung, Taiwan.
Yow-Wen HsiehDepartment of Pharmacy, China Medical University Hospital, Taichung, Taiwan.
Fung-Chang SungDepartment of Public Health, China Medical University, Taichung, Taiwan.
China Medical University · TWChina Medical University Hospital · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectiveFew studies have evaluated the hip fracture risk for zolpidem users. We assessed the risk for subjects taking zolpidem.

designPopulation-based retrospective cohort study using claims data of a universal insurance system.

participantsWe identified 6,978 patients newly prescribed for zolpidem in 2000-2001 age 18 y and older, and 27,848 nonusers frequency matched with sex, age, and date visiting a clinic. MEASUREMENTS AND

resultsBoth cohorts were followed up to the end of 2008 to measure the hip fracture incidence and risk, which considered factors such as sex, age, occupation, days of drug use, and osteoporosis status. The zolpidem users had a 2.23-fold higher hip fracture incidence than nonusers (3.10 versus 1.39 per 1,000 person-y). The risk increased with age for both cohorts. The elderly users had a 21-fold higher incidence than the younger users, or twofold higher than the elderly nonusers. Among 33 patients (20.4%) with hip fracture occurring during presumed medication days, which was accountable for an incidence of 1,083.0 per 1,000 person-y. Those taking the medicine for 8 days or longer had a moderately higher fracture rate than those taking it for less days (6.02 versus 4.48 per 100 person-times) with a ratio of 1.34 (95% confidence interval 0.42-4.56). Subjects with blue collar occupations were at a higher fracture risk.

conclusionThe hip fracture risk of zolpidem users is higher than that of nonusers. Fracture prevention awareness should be disseminated to the users.

Indexed as

AdolescentAdultAgedCohort StudiesFemaleHip FracturesHumansHypnotics and SedativesIncidenceInsurance Claim ReportingKaplan-Meier EstimateMaleMiddle AgedOsteoporosisPyridinesRetrospective StudiesHypnotics and SedativesPyridinesZolpidemHip fracturehypnoticsosteoporosisretrospective cohort studyzolpidem

Identifiers

PMID24899758
PMCPMC4044749
OpenAlexW2040248153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.